MindMed's CAD$25-million bought deal financing becomes a $30 million financing -- the same day.
Appellation program, cooperatives might give small California cannabis farmers a boost
Small marijuana farmers in California who’ve struggled in recent years – either to launch their own brands, expand their businesses or survive the transition to the new legal market – might have a brighter future, thanks in part to various programs and ventures now in the works.
Election underscores voter shift in favor of marijuana legalization
An analysis of votes cast for marijuana ballot measures in 2020 shows that while voters remain divided over legalization based on political affiliation and geography, the overall electorate has shifted in favor of accepting both medical and adult-use cannabis.
New York Marijuana Legalization Support Is Higher Now Than Ever Before, Poll Finds
New York voters support legalizing marijuana by a nearly two-to-one ratio, according to a new poll released on Tuesday.
MindMed Announces 2nd $25 Million Bought Deal Public Offering
MindMed's most recent financing is at nearly double where it priced units just 6 weeks earlier.
MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines
MindMed launches its digital medical division.
Decriminalizing Psychedelics in D.C., Explained
As many have noted, the real winner of this year’s election—which mostly thanks to a spineless Republican party, remains dogged by completely baseless accusations of voter fraud by President Trump—was drug decriminalization.
Maine’s First Month Of Legal Marijuana Sales Total $1.4M
Licensed cannabis retailers in Maine sold more than $1.4 million worth of marijuana products during the first month of legal recreational pot sales, according to data released by state regulators on Monday.
Marijuana Legalization Is Inevitable In New York, Especially After New Jersey Vote, Top Senator Says
Marijuana legalization is an inevitability in New York, a top senator said on Monday, adding that the push is being bolstered by voter approval of cannabis reform next door in New Jersey.
Why An ATAI IPO Is Driving MindMed Stock
ATAI Life Sciences is going public. MindMed Inc is hitting new highs. The two events ARE connected.
Novamind Closes Oversubscribed CAD$10 Million Private Placement
Novamind has closed on double its original target (CAD$5 million). Preparing to commence trading on the CSE (symbol "NM").
ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round
With ATAI eying a Spring 2021 IPO, it announces a $125 million private equity financing for Series C.
